{"id":19428,"date":"2011-02-25T16:24:02","date_gmt":"2011-02-25T20:54:02","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=19428"},"modified":"2011-02-26T16:24:13","modified_gmt":"2011-02-26T20:54:13","slug":"articulos-cientificos-edicion-286","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/19428","title":{"rendered":"Art\u00edculos cient\u00edficos Edici\u00f3n 286"},"content":{"rendered":"<ul>\n<li><a href=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2011\/02\/Evidence-for-Clinical-Safety.pdf\" target=\"_blank\">Evidence for Clinical Safety, Efficacy, and Parent and Physician Perceptions of Levocetirizine<\/a> for the Treatment of Children with Allergic Disease.<\/li>\n<li><a href=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2011\/02\/Treatment-of-autoimmune-urticaria.pdf\" target=\"_blank\">Treatment of autoimmune urticaria with low-dose cyclosporin A<\/a>: A one-year follow-up.<\/li>\n<li><a href=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2011\/02\/Hypocomplementemic.pdf\" target=\"_blank\">Hypocomplementemic vasculitis<\/a> treated with dapsone.<\/li>\n<li><a href=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2011\/02\/Kawasaki.pdf\" target=\"_blank\">Kawasaki disease in 76 patients<\/a>. Risk factors for coronary artery aneurysms.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Evidence for Clinical Safety, Efficacy, and Parent and Physician Perceptions of Levocetirizine for the Treatment of Children with Allergic Disease. Treatment of autoimmune urticaria with low-dose cyclosporin A: A one-year follow-up. Hypocomplementemic vasculitis treated with dapsone. Kawasaki disease in 76 patients. Risk factors for coronary artery aneurysms.<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"class_list":["post-19428","post","type-post","status-publish","format-standard","","category-articulos-cientificos"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/19428","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=19428"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/19428\/revisions"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=19428"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=19428"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=19428"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}